Conformis Announces Achievement of Second Milestone Under Development and License Agreements
20 août 2020 07h30 HE
|
Conformis, Inc.
BILLERICA, Mass., Aug. 20, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that it completed the second of three milestones pursuant to the License Agreement and Development...
Yield10 Bioscience Announces Second Quarter 2020 Financial Results
11 août 2020 16h05 HE
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today reported financial results for the three and six months ended June...
UPD Holding Corp. Announces License of Record Street Brand and Expansion of Nevada Beer Offerings
21 juil. 2020 09h30 HE
|
UPD Holding Corp.
RENO, Nev., July 21, 2020 (GLOBE NEWSWIRE) -- UPD Holding Corp. (OTC:UPDC) (the “Company” or “UPDC”), a consumer products development company with concentrations in the specialty beverage and health...
Biofrontera AG enters into exclusive license agreement with Maruho Co., Ltd.
20 avr. 2020 04h20 HE
|
Biofrontera AG
Leverkusen, Germany, April 20, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (“Biofrontera” or the “Company”), an international biopharmaceutical company, has...
Dermavant Enters into Exclusive License Agreement with JT for Development and Commercialization of Tapinarof in Japan
15 janv. 2020 02h39 HE
|
Dermavant Sciences, Inc.
JT and its subsidiary, Torii Pharmaceutical, receive rights to develop and commercialize tapinarof for psoriasis and atopic dermatitis in Japan Dermavant to receive an upfront payment of $60 million,...
Onconova Therapeutics Announces Exclusive License Agreement with Specialised Therapeutics for Rigosertib in Australia and New Zealand
18 déc. 2019 09h00 HE
|
Onconova Therapeutics, Inc.
Specialised Therapeutics receives exclusive license to commercialize rigosertib in Australia and New ZealandOnconova to be eligible to receive up to US $30.4 million in clinical, regulatory, and...
Yield10 Bioscience Signs Research Agreement with J. R. Simplot to Evaluate New Traits to Produce High Yielding, Sustainable Potato Crop
23 oct. 2019 08h30 HE
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Oct. 23, 2019 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) today announced that it has signed a research agreement with Boise, Idaho-based J. R. Simplot Company, to...
Co-Diagnostics, Inc. and LGC, Biosearch Technologies Expand License Agreement for CoPrimer™ Technology
04 sept. 2019 06h30 HE
|
Co-Diagnostics
Salt Lake City, Utah, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX) (“Co-Diagnostics,” or the “Company”), a molecular diagnostics company with a unique, patented platform...
PROCESSA PHARMACEUTICALS ANNOUNCES THE LICENSING OF AN ANTI-FIBROTIC, ANTI-INFLAMMATORY DRUG FOR THE TREATMENT OF MULTIPLE UNMET MEDICAL NEED CONDITIONS
03 sept. 2019 09h30 HE
|
Processa Pharmaceuticals, Inc.
HANOVER, MD, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (OTCQB: PCSA), a clinical stage biopharmaceutical company developing products to improve the survival and/or quality of...
American International Holdings Corp Executes Exclusive License Agreement to Establish Novopelle Locations Worldwide
05 juil. 2019 09h00 HE
|
American International Holdings Corp.
HOUSTON, TX, July 05, 2019 (GLOBE NEWSWIRE) -- American International Holdings Corp. (OTC: AMIH, or the “Company”) is pleased to announce that it has entered into an exclusive, irrevocable license...